{"brief_title": "Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults", "brief_summary": "This is a placebo controlled study evaluating the efficacy and safety of medication in adults with Attention-Deficit Hyperactivity Disorder (ADHD).", "condition": ["Attention Deficit Disorder"], "intervention_type": ["Drug"], "intervention_name": ["Extended-release bupropion hydrochloride"], "criteria": "Inclusion criteria: - Patient must be diagnosed with ADHD. Exclusion Criteria: - Patient has a current or past history of seizure disorder, brain injury, anorexia nervosa or bulimia. - Patient has a current diagnosis of Major Depressive Disorder (MDD). - Patient has a current primary diagnosis of, or received treatment for, Panic Disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD) or Acute Stress Disorder within the previous 12 months. - Patient has a lifetime diagnosis of bipolar disorder, schizophrenia or other psychotic disorders. - Patient has a positive urine test at screening for presence of illicit drugs or alcohol abuse during the past 12 months.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "60 Years", "healthy_volunteers": "No", "keyword": "hyperactivity", "mesh_term": ["Disease", "Attention Deficit Disorder with Hyperactivity", "Hyperkinesis", "Bupropion"], "id": "NCT00048360"}